Vitamin D and cancer

Area of Science:

• Oncology
• Molecular Biology
• Endocrinology

Background:

• Dietary intake significantly influences cancer etiology and pathophysiology.
• The vitamin D receptor (VDR), a nuclear receptor, responds to 1α25(OH)₂D₃ and plays roles in bone health, cell growth, division, and differentiation.
• VDR's role in regulating cell physiology has led to interest in its therapeutic potential for malignancies.

Purpose of the Study:

• To explore the potential of targeting the vitamin D receptor (VDR) in cancer chemoprevention and chemotherapy.
• To investigate the mechanisms of resistance developed by cancer cells against VDR-targeted therapies.
• To identify strategies for overcoming resistance and enhancing the efficacy of VDR-centered therapeutics.

Main Methods:

• In vitro and in vivo experimental models were utilized to study VDR function in cancer.
• Analysis of de novo and acquired resistance mechanisms in cancer cells.
• Development of experimental and clinical strategies to target VDR and overcome resistance.

Main Results:

• The vitamin D receptor (VDR) influences cell and tissue physiology relevant to cancer development.
• VDR activation regulates cell growth, division, and differentiation.
• Cancer cells exhibit resistance mechanisms to VDR-targeted therapies, necessitating further research.

Conclusions:

• Targeting the VDR presents a promising avenue for cancer chemoprevention and chemotherapy.
• Understanding and overcoming cancer cell resistance to VDR-targeted agents is crucial for therapeutic success.
• Ongoing research focuses on developing novel strategies to enhance the efficacy of VDR-centered cancer treatments.